-
Altfeld M, Rosenberg E S. The role of CD4+ T helper cells in the cytotoxic T lymphocyte response to HIV-1[J]. Curr Opin Immunol, 2000, 12(4): 375-380. doi: 10.1016/S0952-7915(00)00103-5
-
Amara R R, Villinger F, Altman J D. Control of a mucosal challenge and prevention of AIDS by a multi-protein DNA/MVA vaccine[J]. Science, 2001, 292(5514): 69-74. doi: 10.1126/science.1058915
-
Andre S, Seed B, Eberle J. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage[J]. J Virol, 1998, 72(2): 1497-1503.
-
Betts M R, Ambrozak D R, Douek D C. Analysis of total human immunodeficiency virus (HIV)-specific CD4 (+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection[J]. J Virol, 2001, 75(24): 11983-1991. doi: 10.1128/JVI.75.24.11983-11991.2001
-
Bitzer M, ArmeanuS , Lauer U M. Sendai virus vectors as an emerging negative-strand RNA viral vector system[J]. J Gene Med, 2003, 5(7): 543-553. doi: 10.1002/(ISSN)1521-2254
-
Borrow P, Lewicki H, Hahn B H. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodefi-ciency virus type 1 infection[J]. J Virol, 1994, 68(9): 6103-6110.
-
Geldmacher C, Currier J R, Herrmann E. CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients[J]. J Virol, 2007, 81(5): 2440-2448. doi: 10.1128/JVI.01847-06
-
Hasan M K, Kato A, Shioda T. Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3' proximal first locus[J]. J Gen Virol, 1997, 78(): 2813-2820. doi: 10.1099/0022-1317-78-11-2813
-
Im E J, Nkolola J P, di Gleria K. Induction of long-lasting multi-specific CD8+ T cells by a four-component DNA-MVA/HIVA-RENTA candidate HIV-1 vaccine in rhesus macaques[J]. Eur J Immunol, 2006, 36(10): 2574-2584. doi: 10.1002/(ISSN)1521-4141
-
Kano M, Matano T, Nakamura H. Elicitation of protective immunity against simian immunodeficiency virus infection by a recombinant Sendai virus expressing the Gag protein[J]. AIDS, 2000, 14(9): 1281-1282. doi: 10.1097/00002030-200006160-00030
-
Kano M, Matano T, Kato A. Primary replication of a recombinant Sendai virus vector in macaques[J]. J Gen Virol, 2002, 83(Pt6): 1377-1386.
-
Kato A, Sakai Y, Shioda T. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense[J]. Genes Cells, 1996, 1(): 569-579. doi: 10.1046/j.1365-2443.1996.d01-261.x
-
Kiepiela P, Nqumbela K, Thobakqale C. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load[J]. Nat Med, 2007, 13(1): 46-53. doi: 10.1038/nm1520
-
Kong W, Tian C, Liu B. Stable expression of primary human immunodeficiency virus type 1 structural gene products by use of a noncytopathic sindbis virus vector[J]. J Virol, 2002, 76(22): 11434-11439. doi: 10.1128/JVI.76.22.11434-11439.2002
-
Leligdowicz A, Yindom L M, Onyango C. Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection[J]. J Clin Invest, 2007, 117(10): 3067-3074. doi: 10.1172/JCI32380
-
Novitsky V, Cao H, Rybak N. Magnitude and frequency of cytotoxic T-lymphocyte responses: identifi-cation of immunodominant regions of human immunodefi-ciency virus type 1 subtype C[J]. J Virol, 2002, 76(20): 10155-10168. doi: 10.1128/JVI.76.20.10155-10168.2002
-
Prince A M, Whalen R, Brotman B. Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus[J]. Vaccine, 1997, 15(8): 916-919. doi: 10.1016/S0264-410X(96)00248-4
-
Schoenly K A, Weiner D B. Human immunodefi-ciency virus type 1 Vaccine Development: recent Adva-nces in the CTL Platform "Spotty Business"[J]. J Virol, 2008, 82(7): 3166-3180. doi: 10.1128/JVI.01634-07
-
Takeda A, Igarashi H, Nakamura H. Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model[J]. J Virol, 2003, 77(17): 9710-9715. doi: 10.1128/JVI.77.17.9710-9715.2003
-
Toapanta F R, Craigo J K, Montelaro R C. Reduction of anti-HIV-1 Gag immune responses during co-immunization: immune interference by the HIV-1 envelope[J]. Curr HIV Res, 2007, 25(2): 199-209.
-
Urwitz J L, Soike K F, Sangster M Y. Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one[J]. Vaccine, 1997, 15(5): 533-540. doi: 10.1016/S0264-410X(97)00217-X
-
Wolff J A, Malone R W, Williams P. Direct gene transfer into mouse muscle in vivo[J]. Science, 1990, 247(4949Pt1): 1465-1468.
-
Yasutomi Y, Reimann K A, Lord C I. Simian immunodeficiency virus-specific CD8+lymphocyte response in acutely infected rhesus monkeys[J]. J Virol, 1993, 67(3): 1707-1711.
-
Yu D, Shioda T, Kato A. Sendai virus-based expression of HIV-1 gp120: reinforcement by the V (-) version[J]. Genes Cells, 1997, 2(): 457-466. doi: 10.1046/j.1365-2443.1997.1340332.x
-
zur Megede J, Chen M C, Doe B. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene[J]. J Virol, 2000, 74(6): 2628-2635. doi: 10.1128/JVI.74.6.2628-2635.2000